Head Of Early Assets, Hematology

AstraZeneca

Gaithersburg, MD, US
Base: $270,221 - $405,332; bonus/equity: short-ter...
Hematology asset commercial strategy
Early clinical development planning
Target product profile definition
The role focuses on transforming patient outcomes by shaping the early hematology pipeline from preclinical through early clinical development

Job Summary

  • The role focuses on transforming patient outcomes by shaping the early hematology pipeline from preclinical through early clinical development.
  • Candidates must possess a strong grasp of hematology disease biology to effectively partner with R&D teams on study design and endpoints.
  • The position offers a competitive annual base pay ranging from $270,221 to $405,332 along with comprehensive benefits including health coverage and retirement plans.

Matching Summary

The role focuses on transforming patient outcomes by shaping the early hematology pipeline from preclinical through early clinical development.

Salary

Base: $270,221 - $405,332; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligible; Benefits: 401(k), paid vacation, holidays, medical, dental, vision coverage

Skills & Requirements

Must-have

  • Hematology asset commercial strategy
  • Early clinical development planning
  • Target product profile definition
  • Market access and pricing strategy
  • Cross-functional matrix leadership

Nice-to-have

  • Experience with TCE and ADC modalities
  • Strong storytelling for senior stakeholders
  • Background in external stakeholder engagement
  • Familiarity with CMC and supply logistics

Key Requirements

  • MD required with hematology training preferred
  • 10+ years biopharma industry experience
  • Direct exposure to TCE, ADC, and small molecule modalities
  • Proven success at commercial-R&D interface

Work Rights

Not specified

Tailored Resume

Cover Letter